In silico drug repositioning based on integrated drug targets and canonical correlation analysis
Abstract Background Besides binding to proteins, the most recent advances in pharmacogenomics indicate drugs can regulate the expression of non-coding RNAs (ncRNAs). The polypharmacological feature in drugs enables us to find new uses for existing drugs (namely drug repositioning). However, current...
Saved in:
Main Authors: | Hailin Chen (Author), Zuping Zhang (Author), Jingpu Zhang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Strategies for Prospective Drug Repositionings
Published: (2022) -
In Silico Strategies for Prospective Drug Repositionings
Published: (2023) -
Drug repositioning: A bibliometric analysis
by: Guojun Sun, et al.
Published: (2022) -
Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
by: Yuchen Zhang, et al.
Published: (2022) -
Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site
by: Utid Suriya, et al.
Published: (2022)